dr. robert z orlowski on the importance of the phase iii swog s0777 trial
Published 8 years ago • 260 plays • Length 2:11Download video MP4
Download video MP3
Similar videos
-
1:32
dr. orlowski on bortezomib added to lenalidomide and dexamethasone for multiple myeloma
-
2:34
swog s0777 trial: lenalidomide, dexamethasone and bortezomib for the treatment of mm
-
1:15:33
healthtree podcast for multiple myeloma: dr. robert orlowski on myeloma in 2022
-
1:08:09
myeloma crowd radio: robert z. orlowski, md, phd, md anderson cancer center
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
6:07
blood analysis in multiple myeloma
-
25:46
multiple myeloma
-
1:29
meet multiple myeloma specialist robert orlowski, m.d., ph.d.
-
1:22
remaining questions with multiple myeloma treatment
-
57:38
mpatient myeloma radio: dr. robert orlowski, md, phd, md anderson
-
24:30
discussion on current issues in multiple myeloma (mm)
-
3:02
looking to the future of myeloma care
-
54:56
innovative therapeutic concepts for asct-eligible patients with myeloma
-
55:21
the rise of novel antibodies in multiple myeloma
-
5:50
how do you find out about clinical trials?
-
3:11
why should a myeloma patient who has a previous history of bone lesions have a bone study?
-
4:23
upfront therapy approaches in myeloma
-
2:34
two clinical trials using combination therapy in adult patients with multiple myeloma
-
6:42
other agents for treating myeloma
-
26:55
dr robert hensen: advances in multiple myeloma (part 1)
-
1:06
dr. thompson on the future of treatment in multiple myeloma
-
20:04
international myeloma workshop 2013: relapsed/refractory disease